Home
Prescient Therapeutics Ltd
Phase 1b/2 Ovarian Trial Commences 2nd Dose Escalation
Business
Dec 8 2016
4 min read

Phase 1b/2 Ovarian Trial Commences 2nd Dose Escalation

news images

Prescient Therapeutics Ltd has released a press release.

View Attachment

Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren